by Nicholas Mitsakos | AI Agents, Artificial Intelligence, Biotechnology, drug discovery, Public Policy, Technology, Transformative businesses, Writing and Podcasts
Must the AI frontier slow down? Perhaps. But that is not the right question. We should ask what, precisely, must slow; what risk that restraint would reduce; who could enforce it; and what would happen if careful firms paused while less careful actors did not.
Dario Amodei has published one of the most consequential essays yet written by a frontier AI company leader. He is candid, and he is reconsidering an earlier, more benign, position. But his argument is flawed: a model’s capability is not an application or an outcome.
He says the latest models can offer dramatically good or dramatically bad outcomes. On the one hand, AI may cure most major diseases within five to ten years. But it may also become an agent swarm capable of seizing the internet within six to twelve months.
Both are wrong. These extremes are oversimplifications and can undermine both AI’s benefits in many areas and our ability to regulate and monitor it appropriately. Simply saying “boo” and hoping everyone else is frightened isn’t an effective, comprehensive strategy for addressing a serious issue.
Any good or bad from an AI model only appears when that model is part of a system that enters the world through software, capital, organizations, machines, biological systems, and public institutions. Understanding this lets us unleash AI’s potential for good while also building the systems and processes to protect society.
by Nicholas Mitsakos | Artificial Intelligence, Book, Innovation, Technology, Transformative businesses, Writing and Podcasts
We are told that we have entered an unprecedented era. Perhaps. The more useful response is to step back. Perspective does not diminish technological achievement. It allows us to distinguish engineering from magic, capability from consequence, and a genuine inflection point from a fashionable narrative. This book is about that distinction.
Artificial intelligence is a powerful tool that can make tools. But capability is not destiny. Its value and its danger emerge only when it enters real systems: energy, software, capital, organizations, machines, biology, and political institutions.
by Nicholas Mitsakos | AI Agents, Artificial Intelligence, Human learning, Innovation, Technology, Training, Transformative businesses, Writing and Podcasts
The future of AI will be systems that enter an environment, build memories, recognize gaps, ask questions, conduct experiments, model consequences, learn from people, and revise themselves under controlled conditions. AI will become an experiential learning tool. This transition would reduce dependence on internet-scale data, redistribute competitive advantage, accelerate robotics and autonomous science, strengthen specialized and sovereign AI, and create entirely new governance challenges. The next great advance in artificial intelligence may not be a machine trained on everything. It may be a machine that knows how to learn what matters.
by Nicholas Mitsakos | AI Agents, Artificial Intelligence, Biotechnology, Book Chapter, crispr, drug discovery, Health Care, Transformative businesses, Writing and Podcasts
AI cures disease only if the cures already are within a set we have measured, waiting for a better approach. One problem: they do not. Most of human biology has never been observed with detail and understanding sufficient to target a therapy. No amount of inference recovers data that was never collected. The need for AI in life sciences and drug discovery is indisputable. Of roughly ten thousand known human diseases, the large majority have no approved therapy at all; among rare diseases, the figure approaches ninety-five percent. Most approved drugs slow a disease rather than stop it. For the bulk of human illness, medicine offers management or nothing. Humans are systems, and the hardest diseases are within human systems and unsolved. The constraint is not intelligence. It is understanding the system.
by Nicholas Mitsakos | Artificial Intelligence, Biotechnology, Book, China, drug discovery, energy, Globalization, Innovation, Physical Intelligence, Robotics, Science, space, Technology, Transformative businesses, Writing and Podcasts
Technological, geopolitical, and capital transformation are interconnected, with unprecedented impacts on a globally connected, directly entangled economic and geopolitical world. Choices are simultaneously investment decisions, national security decisions, and civilizational bets on which technological architecture will define the next century.
Understanding them requires insightful economic, strategic, and institutional thinking. More than ever, it requires intellectual courage and patience with complexity.
by Nicholas Mitsakos | Artificial Intelligence, Biotechnology, Book Chapter, Health Care, Innovation, Science, Transformative businesses, Writing and Podcasts
Artificial intelligence is no longer a tool that the life sciences industry is adopting. It is a force that is relocating where value is created and who captures it. Three costs are collapsing at once: drug discovery, company independence, and the ability to reach the patient. Each of these costs was, for forty years, a moat protecting the incumbents who could afford to pay it. In addition, the capacity to discover and manufacture medicine has become a strategic infrastructure in the same category as energy, semiconductors, and compute. The molecule has become computable. The architecture of value creation in life sciences has changed.
by Nicholas Mitsakos | AI Agents, Artificial Intelligence, Book Chapter, drug discovery, energy, Financial Technology, Health Care, Innovation, Robotics, Transformative businesses, Writing and Podcasts
Artificial intelligence is a stack: energy, silicon, cloud, models, and applications. Each has its own economics, competitive dynamics, and challenges. Mistaking one layer for the whole industry causes confusion, misrepresentation, bad decisions, and misguided capital allocations. The infrastructure builders enable the platform; the application builders capture the value. The question is now, what value does all this deliver? Energy, silicon, cloud, and models only serve to deliver that product. There is a robust argument that we are at the beginning of an unprecedented value-creation curve. Built on the infrastructure and services provided by the other layers of the stack, the AI application layer will be globally transformative and disruptive. The constraints are imagination, execution, and the willingness to rebuild how work is done.
by Nicholas Mitsakos | AI Agents, Artificial Intelligence, Innovation, irrationality, software, Technology, Transformative businesses, Writing and Podcasts
Autonomous shopping agents, co-working and research agents, and coding agents that write, test, and deploy software. The demos are impressive and the announcements relentless, but how much economic value is any of this generating? Almost all AI-related spending is capital expenditure. Companies are buying chips, building data centers, and scaling up cloud capacity. This is spending on AI infrastructure, not productivity from AI deployment. AI is in the infrastructure buildout phase, not the value capture phase. Mass spending is generating minimal returns, but the market has decided to price the dream rather than the earnings. Can any of this translate into economic reality before the capital runs out and political patience expires? Infrastructure, capability, and revenue growth are happening. Productivity is developing. But a significant gap still exists between capital investment and return on that investment. AI is risky, but these investments are not irrational. They are pricing the dream, and the long-term winners remain unclear.
by Nicholas Mitsakos | Artificial Intelligence, Book Chapter, Innovation, Investment Principles, software, Transformative businesses, Writing and Podcasts
AI models produce raw intelligence. They generate tokens. But tokens are an intermediate good, not a finished product. What customers actually pay for is legal work completed, code shipped, claims processed, research synthesized, and decisions supported.
They pay for refined output.
Attention has focused on the infrastructure layer — the frontier labs, the compute stack, and the data centers. That attention is not misplaced, but it overlooks a structural shift already underway. Once you understand the model as an intermediate good rather than the end product, the center of gravity moves. The decisive question is no longer who can produce intelligence, but who can turn it into something usable, trusted, repeatable, and economically defensible.
In other words, who can refine it into a usable product?
At the base of the chain sit the token producers — OpenAI, Anthropic, Google DeepMind, Meta, DeepSeek, and Qwen. They produce raw capability. This layer is expensive to build, technically formidable, and still moving fast. But crude oil is not gasoline.
Enterprises and consumers pay for gasoline.
by Nicholas Mitsakos | Artificial Intelligence, Book Chapter, Innovation, space, Transformative businesses, Writing and Podcasts
Space is no longer a frontier. For most of the modern era, space has been misunderstood—not technologically, but economically.
Space was a destination rather than a system and a heroic engineering challenge rather than an industrial platform with a continuous operational, and commercial potential. Many early “commercial space” narratives sought to impose venture logic on a domain that remained structurally dependent on government capital, prestige economics, and one-off missions. The result was predictable: excitement without durability, valuation without cash flow, and ambition without a stable market. Now, space is about economic persistence: building businesses that treat space not as a product but as a technological and economic stack – a physical layer supporting a stack of software services and networks.
by Nicholas Mitsakos | Artificial Intelligence, Innovation, Physical Intelligence, Robotics, Transformative businesses, Writing and Podcasts
The wheel was a great invention. But not until it was combined with other wheels to create a usable cart was it an innovation. The wheel was a breakthrough; a moving, stable cart was a system. Systems create intelligent, scalable, and disruptive technology. Innovations are not new technologies. Breakthroughs are necessary, but it’s systems that are the solution. The value created by AI in the physical world is not scaling software. It is focus, discipline, and constraint within effective systems. The systems that endure will not be those that promise universality, but those that dominate specific economic niches, involve humans strategically, and survive year ten of operation.
by Nicholas Mitsakos | Artificial Intelligence, Book Chapter, Innovation, Physical Intelligence, Technology, Transformative businesses, Writing and Podcasts
Robotics and related technology are ready for deployment, but the industry hasn’t crossed the threshold into full-scale production. Computational breakthroughs in stunning demonstrations are attention-grabbing, but the realities of industry quickly take over. There is a gap between robotics and artificial intelligence (“physical intelligence”) as it transitions from potential to hardware delivery in a demanding industrial setting. Physical AI and its integration into robotics may become one of the largest markets in history. But it is an industrial problem whose solution is not on a software timeline. In other words, its commercial deployment requires much more systems integration and real-world constraints than a software slide deck contemplates.
